SynthesisPloS one2020

Comparisons between dipeptidyl peptidase-4 inhibitors and other classes of hypoglycemic drugs using two distinct biomarkers of pancreatic beta-cell function: A meta-analysis.

Masahiro Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.